The latest news updates from the 2024 Symposium
-
Thank you for making the 2023 SABCS® a success
Read More: Thank you for making the 2023 SABCS® a successThe 2023 SABCS® was a huge success, with record attendance and number of submitted abstracts. The premier symposium for breast cancer research, care, and advocacy had plenty of new features, as well as the robust science that is the meeting’s hallmark.
-
Year in Review summarizes important developments in breast cancer from 2023
Read More: Year in Review summarizes important developments in breast cancer from 2023Heide L. Ford, PhD; Jennifer K. Richer, PhD; Ann Partridge, MD, MPH; and Mariana Chavez Mac Gregor, MD, MSC, FASCO, outlined updates across the spectrum of breast cancer research and clinical practice.
-
Panelists highlight what they learned, next steps in View from the Trenches
Read More: Panelists highlight what they learned, next steps in View from the TrenchesExperts reviewed the updates from the 2023 SABCS® that may have an immediate impact for patients and physicians.
-
Tumor-agnostic therapies advance possibilities for precision medicine
Read More: Tumor-agnostic therapies advance possibilities for precision medicineVivek Subbiah, MD, and fellow panelists explored how genomics are driving a new era of tumor-agnostic therapies for cancer in which drugs are approved for biomarkers rather than cancer types.
-
Friday General Session features late-breaking data from KATHERINE and INAVO120 clinical trials
Read More: Friday General Session features late-breaking data from KATHERINE and INAVO120 clinical trialsFindings from 11 studies were presented Friday during the third and final General Session of the 2023 SABCS®.
-
AACR Outstanding Investigator outlines need for better metastatic breast cancer models
Read More: AACR Outstanding Investigator outlines need for better metastatic breast cancer modelsAlana L. Welm, PhD, on Friday discussed what she was doing to model metastatic breast tumors using patient-derived xenografts and organoids, and she implored her fellow researchers to work together to advance the field.
-
Panelists explore challenging, unresolved breast cancer questions based on real-world case studies
Read More: Panelists explore challenging, unresolved breast cancer questions based on real-world case studiesAudience members brought real-world clinical cases and concerns before a multidisciplinary panel on Thursday, prompting discussions about choosing optimal care and treatment for patients with breast cancer in routine practice.
-
Panel underscores utility, importance of molecular/genomic testing in breast cancer practice
Read More: Panel underscores utility, importance of molecular/genomic testing in breast cancer practicePedram Razavi, MD, PhD, moderated a Wednesday session that leveraged challenging, complex clinical cases to highlight how the range of expertise of a molecular tumor board (MTB) can inform and help optimize patient care and treatment in real-world practice.
-
AACR distinguished lecturer a pioneer in intratumoral heterogeneity
Read More: AACR distinguished lecturer a pioneer in intratumoral heterogeneityAACR Distinguished Lectureship recipient Kornelia Polyak, MD, PhD, FAACR, on Thursday discussed her work on disease transition and profiling the different cell types involved in different stages of breast disease.
-
Basic science workshop demonstrates potential of organoids, genomic data, computational biology
Read More: Basic science workshop demonstrates potential of organoids, genomic data, computational biologyPresenters including Calvin J. Kuo, MD, PhD, discussed basic science developments such as the role of organoids, single-cell sequencing, clinical genomics, and molecular docking.